Diabetes Clinical Trials in Los Angeles

Showing 161-180 of 280 trials

Behavioral Economics Incentives for Health Management

NCT01823458

Incentives are increasingly being used to motivate health behavior in medical studies. Small cash payments conditional on certain health and welfare promoting behaviors have shown efficacy in both real world and experimental settings. Furthermore, in incentive studies, behavioral economics has been shown to amplify behavior change beyond what is possible with simple cash payments, but little is known about how varying incentive payment design may impact health behavior. The goal of the present study is to evaluate a new incentive payment instrument, lottery insurance, to determine its impact on adherence to the target health behavior, attendance at free exercise classes provided by QueensCare Family Clinics, a safety-net medical clinic.

Type 2 DiabetesObesity

University of Southern California152 participantsStarted Apr 2012

Los Angeles, California, United States

COMPLETEDPHASE2< 1 mile

Study In People With Type 2 Diabetes

NCT00196989

This Phase 2 dose-ranging study will evaluate the efficacy, safety and tolerability of a range of doses of GW677954 compared with placebo over sixteen weeks of treatment in subjects with T2DM (Type 2 Diabetes Mellitus).

Diabetes Mellitus, Type 2

GlaxoSmithKline448 participantsStarted Sep 2005

Birmingham, Alabama, United States • Northport, Alabama, United States • Chandler, Arizona, United States +140 more locations

Behavioral Economics Incentives for Health Management

Study In People With Type 2 Diabetes

Diabetes Trials in Other Cities

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Study of LY2405319 in Participants With Type 2 Diabetes

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

Assessment of an Automatic Closed-loop Insulin Delivery System

Evaluation of an Investigational Blood Glucose Monitoring System

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Other Conditions in Los Angeles